Human Genome Epidemiology Literature Finder
Records 1 - 24 (of 24 Records) |
Query Trace: Breast Neoplasms and ABCC2[original query] |
---|
Irinotecan pathway genotype analysis to predict pharmacokinetics. Clinical cancer research : an official journal of the American Association for Cancer Research 2003 Aug 9 (9): 3246-53. Mathijssen Ron H J, Marsh Sharon, Karlsson Mats O, Xie Rujia, Baker Sharyn D, Verweij Jaap, Sparreboom Alex, McLeod Howard |
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype. Clinical pharmacology and therapeutics 2004 Jul 76 (1): 38-44. Sparreboom Alex, Gelderblom Hans, Marsh Sharon, Ahluwalia Ranjeet, Obach Rosendo, Principe Paola, Twelves Chris, Verweij Jaap, McLeod Howard |
Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants. Pharmacogenetics and genomics 2007 Aug 17 (8): 647-56. Ho Richard H, Choi Leena, Lee Wooin, Mayo Gail, Schwarz Ute I, Tirona Rommel G, Bailey David G, Michael Stein C, Kim Richard |
Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Therapeutic drug monitoring 2008 Oct 30 (5): 559-64. Miura Masatomo, Kagaya Hideaki, Satoh Shigeru, Inoue Kazuyuki, Saito Mitsuru, Habuchi Tomonori, Suzuki Tosh |
Telmisartan pharmacokinetics in Japanese renal transplant recipients. Clinica chimica acta; international journal of clinical chemistry 2009 Jan 399 (1-2): 83-7. Miura Masatomo, Satoh Shigeru, Inoue Kazuyuki, Saito Mitsuru, Habuchi Tomonori, Suzuki Tosh |
Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients. Journal of human genetics 2009 Oct 54 (10): 564-71. Low Siew-Kee, Kiyotani Kazuma, Mushiroda Taisei, Daigo Yataro, Nakamura Yusuke, Zembutsu Hitos |
Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers. Xenobiotica; the fate of foreign compounds in biological systems 2010 Nov 40 (11): 782-9. Akamine Yumiko, Miura Masatomo, Sunagawa Satoko, Kagaya Hideaki, Yasui-Furukori Norio, Uno Tsuka |
Genotype frequencies of selected drug metabolizing enzymes and ABC drug transporters among breast cancer patients on FAC chemotherapy. Basic & clinical pharmacology & toxicology 2010 Jul 107 (1): 570-6. Afsar Nasir Ali, Haenisch Sierk, Mateen Ahmed, Usman Ahmed, Ufer Mike, Ahmed Khwaja Zafar, Ahmad Hakimuddin Razi, Cascorbi Ingo |
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk. International journal of cancer. Journal international du cancer 2012 Aug 131 (4): 803-12. Campa Daniele, Butterbach Katja, Slager Susan L, Skibola Christine F, de Sanjosé Silvia, Benavente Yolanda, Becker Nikolaus, Foretova Lenka, Maynadie Marc, Cocco Pierluigi, Staines Anthony, Kaaks Rudolf, Boffetta Paolo, Brennan Paul, Conde Lucia, Bracci Paige M, Caporaso Neil E, Strom Sara S, Camp Nicola J, Cerhan James R, Consortium Gec, Canzian Federico, Nieters Alexand |
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.
Human molecular genetics 2012 Apr 21 (7): 1665-72. Kiyotani Kazuma, Mushiroda Taisei, Tsunoda Tatsuhiko, Morizono Takashi, Hosono Naoya, Kubo Michiaki, Tanigawara Yusuke, Imamura Chiyo K, Flockhart David A, Aki Fuminori, Hirata Koichi, Takatsuka Yuichi, Okazaki Minoru, Ohsumi Shozo, Yamakawa Takashi, Sasa Mitsunori, Nakamura Yusuke, Zembutsu Hitos |
Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment. Translational research : the journal of laboratory and clinical medicine 2012 Oct 160 (4): 298-308. Trdan Lušin Tina, Mrhar Aleš, Stieger Bruno, Kullak-Ublick Gerd A, Marc Janja, Ostanek Barbara, Zavratnik Andrej, Kristl Albin, Berginc Katja, Deli? Katja, Trontelj Jur |
Influence of ABCC2, SLCO1B1, and ABCG2 polymorphisms on the pharmacokinetics of olmesartan. Journal of cardiovascular pharmacology 2012 Jul 60 (1): 49-54. Kim Choon O, Cho Sung K, Oh Eun S, Park Min S, Chung Jae-Yo |
Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy. Cancer chemotherapy and pharmacology 2012 May 69 (5): 1221-7. Kim Kyu-pyo, Ahn Jin-Hee, Kim Sung-Bae, Jung Kyung Hae, Yoon Dok Hyun, Lee Jung Shin, Ahn Sei-Hy |
Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen. Pharmacogenomics and personalized medicine 2013 6 93-8. Sensorn Insee, Sirachainan Ekaphop, Chamnanphon Montri, Pasomsub Ekawat, Trachu Narumol, Supavilai Porntip, Sukasem Chonlaphat, Pinthong Daraw |
Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients. Clinical pharmacokinetics 2013 Sep 52 (9): 751-62. Ogasawara Ken, Chitnis Shripad D, Gohh Reginald Y, Christians Uwe, Akhlaghi Fatem |
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast cancer research and treatment 2015 Jul 152 (1): 67-76. Vulsteke Christof, Pfeil Alena M, Maggen Charlotte, Schwenkglenks Matthias, Pettengell Ruth, Szucs Thomas D, Lambrechts Diether, Dieudonné Anne-Sophie, Hatse Sigrid, Neven Patrick, Paridaens Robert, Wildiers Ha |
Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2016 Oct 7 (41): 66790-66808. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Grzybowska E |
ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen. OncoTargets and therapy 2016 9 2121-9. Sensorn Insee, Sukasem Chonlaphat, Sirachainan Ekaphop, Chamnanphon Montri, Pasomsub Ekawat, Trachu Narumol, Supavilai Porntip, Pinthong Darawan, Wongwaisayawan Sansan |
Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer. Cancer chemotherapy and pharmacology 2017 Jun . Tsyganov Matvey M, Freidin Maxim B, Ibragimova Marina K, Deryusheva Irina V, Kazantseva Polina V, Slonimskaya Elena M, Cherdyntseva Nadezhda V, Litviakov Nikolai |
Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients. Clinical breast cancer 2018 May . Jabir Rafid Salim, Ho Gwo Fuang, Annuar Muhammad Azrif Bin Ahmad, Stanslas Johns |
Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018 Feb 9 (10): 9114-9136. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E |
Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial. Pharmacogenetics and genomics 2018 11 28 (11): 245-250. Ruiz-Pinto Sara, Martin Miguel, Pita Guillermo, Caronia Daniela, de la Torre-Montero Julio C, Moreno Leticia T, Moreno Fernando, García-Sáenz José Á, Benítez Javier, González-Neira An |
Role of Four ABC Transporter Genes in Pharmacogenetic Susceptibility to Breast Cancer in Jordanian Patients. Journal of oncology 2019 2019 6425708. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects. European journal of clinical pharmacology 2019 Nov . Cao Kangna, Ren Guanghui, Lu Chengcan, Wang Yao, Tan Yanan, Zhou Jing, Zhang Yongjie, Lu Yang, Li Ning, Chen Xijing, Zhao |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: